Home › Funds › AQR Capital Management › MRK

AQR Capital Management position in MRK

MERCK & CO. INC. · Health Care

AQR Capital Management reported holding 8,134,262 shares of MRK (MERCK & CO. INC.) in its Q2 2026 13F filing — a position valued at US$1.04B, representing 0.36% of its reported portfolio and ranking #35 among its reported holdings. AQR Capital Management has disclosed MRK holdings in 20 of the last 20 reported quarters, going back to Q3 2021.

Latest position (Q2 2026)8.13M sh
Reported value held$1.04B
Portfolio Weight0.36%
First reportedQ3 2021
Last changeReduce
Updated2026-10-05

Last updated: 2026-10-05 · Source: SEC EDGAR Form 13F-HR

How AQR Capital Management's MRK position evolved

AQR Capital Management first disclosed a stake in MRK in Q3 2021 at 4,849,316 shares (US$364.2M). The position peaked in Q4 2025 at 11,249,363 shares, worth US$1.18B. Across 20 filings, AQR Capital Management increased the stake 8 time(s), trimmed it 11 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 8,134,262 shares valued at US$1.04B — a reduction of -494,224 shares quarter over quarter.. Notable position changes include a 37% increase in Q3 2024 (shares fell 12% over the following quarter), a 78% increase in Q4 2024 (shares fell 9% over the following quarter), a 44% increase in Q1 2025 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2021 4.85M $364.23M New
Q4 2021 3.88M $297.51M Reduce
Q1 2022 3.61M $295.91M Reduce
Q2 2022 4.12M $375.20M Add
Q3 2022 3.93M $338.19M Reduce
Q4 2022 3.11M $344.87M Reduce
Q1 2023 2.81M $298.44M Reduce
Q2 2023 2.91M $331.84M Add
Q3 2023 2.55M $262.27M Reduce
Q4 2023 2.34M $254.20M Reduce
Q1 2024 2.24M $294.67M Reduce
Q2 2024 2.21M $273.76M Reduce
Q3 2024 3.02M $343.27M Add
Q4 2024 5.38M $533.10M Add
Q1 2025 7.76M $691.07M Add
Q2 2025 8.79M $690.15M Add
Q3 2025 10.66M $851.37M Add
Q4 2025 11.25M $1.18B Add
Q1 2026 8.63M $1.04B Reduce
Q2 2026 8.13M $1.04B Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRK and 13F data

MRK (MERCK & CO. INC.) is a Health Care company. 29 other funds we track also report a position in MRK — the largest reported positions include BlackRock Inc (US$29.17B), Vanguard Group (US$26.77B), VANGUARD CAPITAL MANAGEMENT LLC (US$20.73B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRK

All MRK fund holders →

FAQ

How long has AQR Capital Management held MRK?

AQR Capital Management has disclosed MRK holdings in 20 of the last 20 reported quarters, going back to Q3 2021.

What is AQR Capital Management's current position in MRK?

As of Q2 2026, AQR Capital Management holds 8.13M shares of MRK (MERCK & CO. INC.), valued at $1.04B, representing 0.36% of its reported portfolio and ranking #35.

Has AQR Capital Management been buying or selling MRK?

In the latest 13F filing (Q2 2026), AQR Capital Management reduced its position in MRK. The position peaked in Q4 2025 at 11.25M shares.

Which other funds hold MRK?

Other major institutional holders of MRK include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.